PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemistry, Sharif University of Technology, Tehran, Iran.\', \'Biomaterial Group, Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran. Electronic address: mrabiee@aut.ac.ir.\', \'Department of Chemistry, Sharif University of Technology, Tehran, Iran. Electronic address: bagherzadeh@sharif.edu.\', \'Research Center for Immunodefiencies, Children\'s Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: rezaei_nima@tums.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0306-9877(20)31015-X10.1016/j.mehy.2020.109917
?:doi
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32505072
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
?:title
  • COVID-19 and picotechnology: Potential opportunities.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all